SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-006916
Filing Date
2024-05-07
Accepted
2024-05-07 08:03:45
Documents
15
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qure-20240507x8k.htm   iXBRL 8-K 35989
2 EX-99.1 qure-20240507xex99d1.htm EX-99.1 144251
3 GRAPHIC qure-20240507xex99d1003.jpg GRAPHIC 8931
  Complete submission text file 0001558370-24-006916.txt   323586

Data Files

Seq Description Document Type Size
4 EX-101.SCH qure-20240507.xsd EX-101.SCH 3403
5 EX-101.LAB qure-20240507_lab.xml EX-101.LAB 15214
6 EX-101.PRE qure-20240507_pre.xml EX-101.PRE 9964
18 EXTRACTED XBRL INSTANCE DOCUMENT qure-20240507x8k_htm.xml XML 4599
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 24919705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)